Denali Therapeutics, Inc. (DNLI)
20.77
+1.23
(+6.29%)
USD |
NASDAQ |
Jun 09, 16:00
20.60
-0.17
(-0.82%)
After-Hours: 20:00
Denali Therapeutics Market Cap : 3.295B for June 9, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Sarepta Therapeutics, Inc. | 1.679B |
| ImmunityBio, Inc. | 7.583B |
| Summit Therapeutics, Inc. | 11.08B |
| Arrowhead Pharmaceuticals, Inc. | 10.31B |
| Biogen, Inc. | 29.40B |
Market Cap Related Metrics
| PEG Ratio | -0.9155 |
| Price to Book Value | 3.558 |
| Price | 20.77 |
| Earnings Yield | -13.87% |
| PEGY Ratio | -0.9155 |